| Proteomics of protein trafficking by in vivo tissue-specific labeling IA Droujinine, AS Meyer, D Wang, ND Udeshi, Y Hu, D Rocco, ... Nature communications 12 (1), 2382, 2021 | 56 | 2021 |
| AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia SB Balachander, SW Criscione, KF Byth, J Cidado, A Adam, P Lewis, ... Clinical Cancer Research 26 (24), 6535-6549, 2020 | 46 | 2020 |
| AZD0466, a nanomedicine of a potent dual Bcl-2/Bcl-xL inhibitor, exhibits anti-tumor activity in a range of hematological and solid tumor models SB Balachander, A Tabatabai, S Wen, FD Gibbons, G Fabbri, GS Zhang, ... Cancer Research 80 (16_Supplement), 56-56, 2020 | 7 | 2020 |
| An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma R Flümann, J Hansen, J Meinel, P Pfeiffer, H Goldfarb Wittkopf, A Lütz, ... Blood Advances 8 (5), 1063-1074, 2024 | | 2024 |
| Mouse models of diffuse large B cell lymphoma A Tabatabai, A Arora, S Höfmann, M Jauch, B Von Tresckow, J Hansen, ... Frontiers in Immunology 14, 1313371, 2023 | | 2023 |
| An In Vivo PiggyBac Insertional Mutagenesis Screen Reveals Oncogenic Lesions Cooperating with Myd88 L265P S Höfmann, R Flümann, J Hansen, S Klein, J Meinel, P Pfeiffer, ... Blood 142, 525, 2023 | | 2023 |
| Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib plus Osimertinib in an EGFR Mutation–Positive, MET-Amplified Non–Small Cell Lung Cancer Model RDO Jones, K Petersson, A Tabatabai, L Bao, H Tomkinson, AG Schuller Molecular Cancer Therapeutics 22 (5), 679-690, 2023 | | 2023 |
| AZD0466, a dual BCL-2/XL targeting nanomedicine, is active in small cell lung cancer models CL Andersen, G Fabbri, D Jenkins, Z Cader, S Sharma, A Tabatabai, ... Cancer Research 83 (7_Supplement), 6150-6150, 2023 | | 2023 |
| Using a pharmacodynamic biomarker led approach to explore and quantify the combination effect of savolitinib and osimertinib in the LG1208 NSCLC PDX model R Jones, A Schuller, K Petersson, G Ahmed, S Schalkwijk, A Tabatabai, ... Cancer Research 80 (16_Supplement), 3017-3017, 2020 | | 2020 |
